Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein

Current Biology

Volumn 9, Issue 12, 1999, Pages 613-621

  Ross, Ted M ^a   Oran, Alp E ^a   Cullen, Bryan R ^b  

^a EMORY UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033578016     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(99)80283-8     Document Type: Article

References (45)

1. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984, 312:763-766.
2. Klatzman D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, et al: T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984, 312:767-768.
3. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R: The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986, 47:333-348.
4. Bieniasz PD, Cullen BR: Chemokine receptors and human immunodeficiency virus infection. Frontiers Biosci 1998, 3:44-58.
5. Doms RW, Peiper SC: Unwelcome guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology 1997, 235:179-190.
6. Cullen BR: HIV-1 auxiliary proteins: making connections in a dying cell. Cell 1998, 93:685-692.
7. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D: Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 1994, 76:853-864.
8. Rhee SS, Marsh JW: Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J Virol 1994, 68:5156-5163.
9. Schwartz O, Marechal V, Le Gal S, Lemmonier F, Heard JM: Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. J Virol 1995, 69:528-533.
10. Garcia JV, Miller AD: Serine phosporylation-independent downregulation of cell-surface CD4 by Nef. Nature 1991, 350:508-511.
11. Benson, RE, Sanfridson A, Ottinger JS, Doyle C, Cullen BR: Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral superinfection. J Exp Med 1993, 177:1561-1566.
12. + cells: mechanism for persistence in AIDS. Cell 1998, 53:483-496.
13. Willey RL, Maldarelli F, Martin MA, Strebel K: Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol 1992, 66:7193-7200.
14. Margottin F, Bour SP, Durand H, Selig L, Benichou S, Richard V, et al: A novel human WD protein, h-βTrCP, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell 1998, 1:565-574.
15. Hua J, Cullen BR: Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef use distinct but overlapping target sites for downregulation of cell surface CD4. J Virol 1997, 71:6742-6748.
16. Anderson SJ, Lenburg M, Landau NR, Garcia JV: The cytoplasmic domain of CD4 is sufficient for its downregulation from the cell surface by human immunodeficiency virus type 1 Nef. J Virol 1994, 68:3092-3101.
17. Greenberg ME, lafrate AJ, Skowronski J: The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J 1998, 17:2777-2789.
18. Le Gall S, Erdtmann L, Benichou S, Berlioz-Torrent C, Liu L, Benarous R, et al.: Nef interacts with μ, subunits of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC-1 molecules. Immunity 1998, 8:483-495.
19. Piguet V, Chen Y-L, Mangasarian A, Foti M, Carpentier J-L, Trono D: Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the μ, chain of adaptor complexes. EMBO J 1998, 17:2472-2481.
20. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D: HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998, 391 397-401.
21. Spina CA, Kwoh TJ, Chowers MY, Guatelli JC, Richman DD: The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J Exp Med 1994, 179:115-123.
22. Miller MD, Warmerdam MT, Gaston I, Greene WC, Feinberg MB: The HIV-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 1994, 179:101-113.
23. Chowers MY, Pandori MW, Spina CA, Richman DD, Guatelli JC: The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology 1995, 212:451-457.
24. Aiken C, Trono D: Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J Virol 1995, 69:5048-5056.
25. Schwartz O, Marchal V, Danos O, Heard J-M: Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J Virol 1995, 69:4053-4059.
26. Saksela K, Cheng G, Baltimore D: Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J 1995, 14:484-491.
27. Alexander L, Du Z, Rosenzweig M, Jung JU, Desrosiers RC: A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 Nef alleles in lymphocyte activation. J Virol 1997, 71:6094-6099.
28. Baur AS, Sawai ET, Dazin P, Fanti WJ, Cheng-Mayer C, Peterlin BM: HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1994, 1:373-384.
29. Kestler H, Ringler D, Mori K, Panicali D, Desrosiers R: Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991, 65:651-662.
30. Kim S, Ikeuchi K, Byrn R, Groopman J, Baltimore D: Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1989, 86:9544-9548.
31. Jamieson BD, Aldrovandi GM, Planelles V, Jowett JB, Gao L, Bloch LM, et al.: Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J Virol 1994, 68:3478-3485.
32. Baba TW, Liska v, Khimani AH, Ray NB, Dailey PJ, Penninck D, et al: Live attenuated, multiply deleted simian immunodeficiency virus (SIV) causes AIDS in infant and adult macaques. Nat Med 1999, 5:194-203.
33. Marshall WL, Diamond DC, Kowalski MM, Finberg RW: High level of surface CD4 prevents stable human immunodeficiency virus infection of T-cell transfectants. J Virol 1992, 66:5492-5499.
34. Connor RL, Sheridan KE, Ceradini D, Choe S, Landau NR: Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 1997, 185:621-628.
35. Ross TM, Cullen BR: The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop. Proc Natl Acad Sci USA 1998, 95:7682-7686.
36. Merkenschlager M, Buck D, Beverley PCL, Sattenau QJ: Functional epitope analysis of the CD4 molecule: the MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless whether or not they recognize epitopes involved in the binding of MHC class II or HIV gp120. J Immunol 1990, 145:2839-2845.
37. Grzesiek S, Bax A, Clore GM, Gronenborn AM, Hu JS, Kaufmann J, et al.: The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nat Struct Biol 1996, 3340-345.
38. Hua J, Blair W, Truant R, Cullen BR: Identification of regions in HIV-1 Nef required for efficient downregulation of cell surface CD4. Virology 1997, 231:231-238.
39. Guy B, Kieny M, Riviere Y, Peuch C, Dott K, Girard M, et al: HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 1987, 330:266-269.
40. Palese P, Tobita K, Ueda M, Compans R: Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 1974, 61:397-410.
41. Liu C, Eichelberger MC, Compans RW, Air GM: Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J Virol 1995, 69:1099-1106.
42. Coffin JM: HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995, 267:483-489.
43. Lu X, Wu X, Plemenitas A, Yu H, Sawai ET, Abo A, et al.: CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Curr Biol 1996, 6:1677-1684.
44. Kinsella TM, Nolan GP: Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 1996, 7:1405-1413.
45. Srinivas RV, Hurwitz JL: In Immunology Methods Manual. Edited by Lefkovits I. London: Academic Press; 1996.